CJC-1295 (No DAC) is a synthetic peptide fragment studied in laboratory and in-vitro research settings for its interaction with growth hormone–releasing hormone (GHRH) receptors. This compound is structurally designed without a Drug Affinity Complex (DAC), resulting in a shorter biological half-life compared to DAC-modified analogs.
In controlled research environments, CJC-1295 (No DAC) is commonly evaluated for its receptor-binding characteristics, signaling pathways, and degradation kinetics. Its rapid clearance profile makes it of interest for studies requiring precise temporal control during experimental observation.
This product is supplied strictly for laboratory research purposes only and is not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease.
$35.00
In stock
CJC-1295 No DAC (2mg) is a high-purity research peptide supplied for laboratory study. Researchers examine this compound in controlled experimental settings to investigate receptor-mediated signaling and peptide pathway interactions. Provided strictly for scientific investigation only.
This compound is evaluated in in-vitro and analytical research settings to observe receptor binding behavior, signaling activity, and peptide stability without long-acting modification.
Supplied as a lyophilized powder, this material should be handled, stored, and reconstituted only by qualified personnel following standard laboratory safety protocols.
For research use only; not for human or animal consumption, not a drug or dietary supplement, and not approved by the FDA or any regulatory authority for therapeutic use.
SS-31 (5 mg) is a synthetic tetrapeptide developed for use in laboratory and analytical research environments, where it is studied for its affinity to mitochondrial membranes and its role in cellular bioenergetic pathways. In non-clinical research contexts, SS-31 is commonly evaluated to better understand mitochondrial structure-function relationships, oxidative stress markers, and peptide–membrane interactions under controlled experimental conditions.
This compound is provided as a lyophilized powder and is intended exclusively for use by qualified professionals trained in the handling of research chemicals. SS-31 is not intended for human or animal use and is not approved for diagnostic, therapeutic, or preventive applications. All handling, storage, and experimental use should follow established laboratory safety protocols and institutional guidelines.
$47.00
CJC-1295 (No DAC) is a synthetic peptide fragment studied in laboratory and in-vitro research settings for its interaction with growth hormone–releasing hormone (GHRH) receptors. This compound is structurally designed without a Drug Affinity Complex (DAC), resulting in a shorter biological half-life compared to DAC-modified analogs.
In controlled research environments, CJC-1295 (No DAC) is commonly evaluated for its receptor-binding characteristics, signaling pathways, and degradation kinetics. Its rapid clearance profile makes it of interest for studies requiring precise temporal control during experimental observation.
This product is supplied strictly for laboratory research purposes only and is not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease.
$35.00
Thymosin Alpha-1 (5mg) is a high-purity research peptide supplied for controlled laboratory investigation. Manufactured under strict quality standards and intended strictly for scientific research environments.
$74.00
Tesamorelin (2mg) is a laboratory-grade peptide studied in growth hormone signaling and metabolic pathway research. Supplied for controlled research use only.
$84.00
TB-500 (5mg) is a synthetic research peptide supplied for laboratory and scientific investigation. This compound is studied in controlled research environments to examine peptide signaling, cellular processes, and molecular interactions. Provided strictly for research use only.
$84.00
Laila Ahmed –
Simple product to work with in our lab. Dissolved cleanly and performed as expected when we monitored GH‑axis signaling patterns in our controlled assays. Packaging was professional and chain‑of‑custody documentation was clear.
Carlos Mendez –
Test batches for activation of GH‑releasing protocols went smoothly. Found peptide stable over our 7‑day chilled storage period before reconstitution. No unexpected shifts in baseline activity.
Sophie Clarke –
I used this peptide across three experimental replicates monitoring IGF‑1 modulation. Results were consistent and reproducible, though I recommend using freshly prepared solutions within a narrow time window to avoid variability.
Elena Petrova –
We examined extended GH release profiles using this vial. Data lined up with known half‑life curves, which was great for modelling recovery kinetics. Packaging was discrete and labeling clear.
Dr. Mark Johnson –
Our peptide yielded predictable GH pulse amplification in vitro. Followed sterile technique strictly and consistent outcomes were achieved across two cell lines. Would recommend for lab research where GH modulation is of interest.
Prof. Trevor Mills –
In tracking recovery markers post mechanical stress in tissue cultures, this peptide helped us see subtle hormonal shifts. Good stability after reconstitution when refrigerated. Only downside: needed careful pipetting to avoid bubbles.
Daniel Jensen –
We ran a short‑term regimen to track quick responsivity of cells to stimulation. Setup was straightforward and results were within anticipated ranges. Slight redness noted at injection points in our animal cohort, resolved quickly.
Laura Schmidt –
Simple vial prep and clear protocol instructions from Patriot Peptides helped our team avoid reconstitution errors. Growth hormone axis signals were robust across trials, which was key for our publication data set.
Dr. Ahmed Al‑Hassan –
Followed a standard peptide reconstitution routine in our tissue culture lab. Observed expected activation patterns without erratic readings. Documentation from the pack was sufficient for our lab compliance records.